CAH · NYSE · STOCK
Cardinal Health (CAH) Stock Analysis
$251.74
52W $152.46 – $258.30
55/100
$56.14B
33.0
0.50
Is CAH Bullish or Bearish?
Mixed.
Innellis AI committee rates Cardinal Health (CAH) Watch with a composite score of 55/100
, based on 6 analysts with 50% agreement.
Last updated October 14, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +5.36 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -14.64 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+0.33 across 31 articles, 14d). Risk Analyst remains cautious — high leverage (debt-to-equity 3.48) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 37.2% shows genuine earnings power backing the valuation — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
- News sentiment is positive (+0.33 across 31 articles, 14d) — News
Bear Case
- P/E of 32.2 is moderate-to-rich — Value
- Price-to-book of 9.2x prices in significant intangible value — Value
- Debt-to-equity of 3.48 adds balance-sheet risk to the value case — Value
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- RSI at 71 is in overbought territory — Technical
- Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 14, 2026
Overall Committee Score
55/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 69%
of 192 Healthcare peers
Value Analyst
neutral
45
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 37.2% shows genuine earnings power backing the valuation
− P/E of 32.2 is moderate-to-rich
Growth Analyst
bullish
60
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ 5 consecutive earnings beats -- consistent execution
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst
neutral
57
/ 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− RSI at 71 is in overbought territory
Risk Analyst
bearish
32
/ 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 3.48) amplifies downside in a stress scenario
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
68
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.33 across 31 articles, 14d)
Portfolio Manager
bearish
35
/ 100 · Low confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− 2 existing position pair(s) are highly correlated already
Investment Thesis Evolution
Committee score weakened from 58.1 to 54.6.
- Committee agreement fell notably from 67% to 50%.
- New bearish signals: 2 appeared.
- Bullish support removed: 2 signal(s) disappeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 2 signal(s) disappeared.
- Analyst(s) changed stance: Technical Analyst.
Analyst-level changes:
- Macro Analyst: score 80->65 (-15).
- News Analyst: +1 bullish signal(s).
- Portfolio Manager: score 30->35 (+5).
- Technical Analyst: stance bullish->neutral; score 63->57 (-6); +1 bearish signal(s).
- Value Analyst: +1 bearish signal(s).
Comparing 2026-10-13 to 2026-10-14 (1 day apart).
Technical Analysis
RSI (14)
81.2
Overbought
MACD Histogram
2.263
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Lh Ll
Support
$220.44
Resistance
$257.95
Bollinger %B
1.08
Above Upper Band
Price vs Moving Averages
EMA 9
$237.35
Above
EMA 21
$233.70
Above
EMA 50
$231.92
Above
EMA 200
$216.23
Above
Fundamental Analysis
Valuation
48
Growth
69
Profitability
8
Financial Health
53
Cash Flow
70
Valuation
P/E Ratio
33.0×
P/B Ratio
-19.62×
PEG Ratio
2.67
Dividend Yield
0.86%
52W High
$258.30
52W Low
$152.46
Quality & Growth
ROE
-5945.2%
ROA
299.1%
Gross Margin
384.4%
Operating Margin
102.8%
Revenue Growth YoY
—
Debt / Equity
-3.45
AI Fundamental Assessment
P/E ratio of 33.0 (rich relative to a 15-40x range); Price-to-book of -19.6x; PEG ratio of 2.7 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -59.5%; Return on assets of 3.0%; Net margin of 0.7%; Gross margin of 3.8%; Current ratio of 0.88 (tight short-term liquidity); Debt-to-equity of -3.45; Free cash flow per share is positive (19.17); Most recent quarter beat estimates by 6.4%; 5 consecutive earnings beats; EPS growth decelerating (+20.5% -> -18.0% QoQ); Average YoY EPS growth of 25.0%; Analyst estimates flat over recent quarters
Get the Full CAH Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →